Newer blood thinner may improve outcomes for heart attack survivors

Long-term use of the newer anti-clotting drug Brilinta cut heart attack survivors' future risk of heart attack, stroke or heart-related death, a new study found. Marc Sabatine, a professor of medicine at Brigham and Women's Hospital, led the study.

Read the full article